Zhejiang AngliKang Pharmaceutical Co Ltd
002940
Company Profile
Business description
Zhejiang AngliKang Pharmaceutical Co Ltd is engaged in the manufacturing and sale of pharmaceutical materials, pharmaceutical preparations, and medical empty capsules. The main products offered by the group are cephalosporin antibacterial, angiocarpy drugs, and gastrointestinal tract drugs. Geographically, the activities are carried out in Shengzhou, China.
Contact
No. 1000, North Luzhou Avenue
Zhejiang Province
Quzhou312400
CHNT: +86 57583100181
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
1,236
Stocks News & Analysis
stocks
ASX healthcare share remains undervalued ahead of earnings
Margin recovery remains the key driver for this ASX healthcare share.
stocks
Alphabet earnings: Strong AI monetization continues to spearhead results
We maintain our fair value estimate for wide-moat Alphabet.
stocks
AMD: We’re pleased with Anthropic Partnership ahead of advancing AI event
We’re encouraged that AMD will count Anthropic as a third leading AI customer, in addition to OpenAI and Meta.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,935.30 | 38.90 | -0.43% |
| CAC 40 | 8,299.09 | 138.80 | -1.64% |
| DAX 40 | 24,763.12 | 392.29 | -1.56% |
| Dow JONES (US) | 51,711.65 | 506.93 | -0.97% |
| FTSE 100 | 10,639.17 | 77.80 | -0.73% |
| HKSE | 24,901.62 | 309.19 | -1.23% |
| NASDAQ | 25,137.69 | 553.21 | -2.15% |
| Nikkei 225 | 64,426.44 | 1,996.16 | -3.01% |
| NZX 50 Index | 13,770.39 | 24.92 | -0.18% |
| S&P 500 | 7,408.30 | 90.66 | -1.21% |
| S&P/ASX 200 | 8,765.30 | 30.40 | -0.35% |
| SSE Composite Index | 3,833.56 | 43.22 | -1.11% |